| Year |
Citation |
Score |
| 2023 |
Shatara M, Blue M, Stanek J, Liu YA, Prevedello DM, Giglio P, Puduvalli VK, Gardner SL, Allen JC, Wong KK, Nelson MD, Gilles FH, Adams RH, Pauly J, O'Halloran K, et al. Final report of the phase II NEXT/CNS-GCT-4 trial: GemPOx followed by marrow-ablative chemotherapy for recurrent intracranial germ cell tumors. Neuro-Oncology Practice. 11: 188-198. PMID 38496907 DOI: 10.1093/nop/npad067 |
0.304 |
|
| 2023 |
Sharma P, Aaroe A, Liang J, Puduvalli VK. Tumor microenvironment in glioblastoma: Current and emerging concepts. Neuro-Oncology Advances. 5: vdad009. PMID 36968288 DOI: 10.1093/noajnl/vdad009 |
0.347 |
|
| 2020 |
Sharma P, Mahadevan LSK, Argall A, Xu J, Sampath D, Puduvalli V. EXTH-54. ENHANCED SENSITIVITY OF HUMAN GLIOMA CELLS FOR TEMOZOLOMIDE (TMZ) BY COMBINING THERAPY WITH HEAT SHOCK PROTEIN 90 Neuro-Oncology. 22: ii99-ii99. DOI: 10.1093/neuonc/noaa215.408 |
0.41 |
|
| 2017 |
Canella A, Welker AM, Yoo JY, Xu J, Abbas FS, Kesanakurti D, Nagarajan P, Beattie CE, Sulman EP, Liu JL, Gumin J, Lang FF, Gurcan M, Kaur B, Sampath D, ... Puduvalli VK, et al. Efficacy of Onalespib a Long-acting Second Generation HSP90 Inhibitor as a Single Agent and in Combination with Temozolomide Against Malignant Gliomas. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28679777 DOI: 10.1158/1078-0432.Ccr-16-3151 |
0.52 |
|
| 2017 |
Puduvalli VK, Chaudhary R, McClugage SG, Markert J. Beyond Alkylating Agents for Gliomas: Quo Vadimus? American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Meeting. 37: 175-186. PMID 28561663 DOI: 10.14694/EDBK_175003 |
0.319 |
|
| 2017 |
Kesanakurti D, Maddirela D, Banasavadi-Siddegowda YK, Lai TH, Qamri Z, Jacob NK, Sampath D, Mohanam S, Kaur B, Puduvalli VK. A novel interaction of PAK4 with PPARγ to regulate Nox1 and radiation-induced epithelial-to-mesenchymal transition in glioma. Oncogene. PMID 28534509 DOI: 10.1038/Onc.2016.261 |
0.526 |
|
| 2017 |
Wu JPJ, Canella A, Xu J, Lai T, Welker AM, Beattie CE, Nadella V, Timmers C, Kaur B, Jacob N, Sampath D, Puduvalli VK. EXTH-83. TARGETING DNA REPAIR AND SURVIVAL PATHWAYS THROUGH HEAT SHOCK PROTEIN INHIBITION USING AT13387 TO SENSITIZE GLIOMA TO CHEMORADIATION THERAPY Neuro-Oncology. 19: vi91-vi91. DOI: 10.1093/Neuonc/Nox168.373 |
0.436 |
|
| 2016 |
Welker AM, Jaros BD, Puduvalli VK, Imitola J, Kaur B, Beattie CE. Correction: Standardized orthotopic xenografts in zebrafish reveal glioma cell-line-specific characteristics and tumor cell heterogeneity. Disease Models & Mechanisms. 9: 1063-5. PMID 27604693 DOI: 10.1242/dmm.027235 |
0.489 |
|
| 2016 |
Geng F, Cheng X, Wu X, Yoo JY, Cheng C, Guo JY, Mo X, Ru P, Hurwitz B, Kim S, Otero J, Puduvalli VK, Lefai E, Ma J, Nakano I, et al. Inhibition of SOAT1 suppresses glioblastoma growth via blocking SREBP-1-mediated lipogenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27281560 DOI: 10.1158/1078-0432.Ccr-15-2973 |
0.416 |
|
| 2016 |
Kesanakurti D, Xu J, Kaur B, Puduvalli V, Canella A. RBIO-06. CROSSTALK OF ErbB2 WITH LEF1 REGULATES JAGGED1-MEDIATED RADIORESISTANCE IN GLIOBLASTOMA Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.726 |
0.448 |
|
| 2016 |
Kesanakurti D, Xu J, Canella A, Jha P, Kaur B, Puduvalli V. Csig-28. Novel Function Of Brachyury As A Potent Regulator Of Hedgehog Signaling And Stemness In Glioma Neuro-Oncology. 18. DOI: 10.1093/Neuonc/Now212.189 |
0.428 |
|
| 2015 |
Welker AM, Jaros BD, Puduvalli VK, Imitola J, Kaur B, Beattie CE. Standardized orthotopic xenografts in zebrafish reveal glioma cell line specific characteristics and tumor cell heterogeneity. Disease Models & Mechanisms. PMID 26659251 DOI: 10.1242/Dmm.022921 |
0.512 |
|
| 2015 |
Canella A, Xu J, Meisen WH, Kaur B, Rizzotto L, Kesanakurti D, Nagarajan P, Puduvalli VK. Abstract 683: DEBIO0932, an Hsp90 inhibitor downregulates key signaling pathways and sensitizes glioma cells to temozolomide Cancer Research. 75: 683-683. DOI: 10.1158/1538-7445.Am2015-683 |
0.476 |
|
| 2015 |
Kesanakurti D, Xu J, Canella A, Nagarajan P, Kaur B, Puduvalli VK. Abstract 4158: Novel PAK4-mediated regulation of endothelial CXCL1/CXCR2 signaling and angiogenesis in glioblastoma Cancer Research. 75: 4158-4158. DOI: 10.1158/1538-7445.Am2015-4158 |
0.525 |
|
| 2015 |
Canella A, Xu J, Yoo JY, Kaur B, Nagarajan P, Kesanakurti D, Puduvalli VK. Atps-05Characterization Of The Activity Of At13387, A Novel Second Generation Hsp90 Inhibitor Against Gliomas Neuro-Oncology. 17. DOI: 10.1093/Neuonc/Nov204.05 |
0.57 |
|
| 2014 |
Thorne AH, Meisen WH, Russell L, Yoo JY, Bolyard CM, Lathia JD, Rich J, Puduvalli VK, Mao H, Yu J, Caligiuri MA, Tridandapani S, Kaur B. Role of cysteine-rich 61 protein (CCN1) in macrophage-mediated oncolytic herpes simplex virus clearance. Molecular Therapy : the Journal of the American Society of Gene Therapy. 22: 1678-87. PMID 24895995 DOI: 10.1038/Mt.2014.101 |
0.479 |
|
| 2011 |
Xu J, Sampath D, Lang FF, Prabhu S, Rao G, Fuller GN, Liu Y, Puduvalli VK. Vorinostat modulates cell cycle regulatory proteins in glioma cells and human glioma slice cultures. Journal of Neuro-Oncology. 105: 241-51. PMID 21598070 DOI: 10.1007/S11060-011-0604-7 |
0.335 |
|
| 2011 |
Liu Y, Lang F, Xie X, Prabhu S, Xu J, Sampath D, Aldape K, Fuller G, Puduvalli VK. Efficacy of adenovirally expressed soluble TRAIL in human glioma organotypic slice culture and glioma xenografts. Cell Death & Disease. 2: e121. PMID 21368892 DOI: 10.1038/Cddis.2010.95 |
0.305 |
|
| 2009 |
Sampath D, Calin GA, Puduvalli VK, Gopisetty G, Taccioli C, Liu CG, Ewald B, Liu C, Keating MJ, Plunkett W. Specific activation of microRNA106b enables the p73 apoptotic response in chronic lymphocytic leukemia by targeting the ubiquitin ligase Itch for degradation. Blood. 113: 3744-53. PMID 19096009 DOI: 10.1182/Blood-2008-09-178707 |
0.309 |
|
| 2008 |
Fine HA, Puduvalli VK, Chamberlain MC, Carpentier AF, Cher L, Mason WP, van den Bent MJ, Hong S, Thornton D, Wick W. Enzastaurin (ENZ) versus lomustine (CCNU) in the treatment of recurrent, intracranial glioblastoma multiforme (GBM): A phase III study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 2005. PMID 27948440 DOI: 10.1200/jco.2008.26.15_suppl.2005 |
0.303 |
|
| 2004 |
Puduvalli VK. Inhibition of angiogenesis as a therapeutic strategy against brain tumors. Cancer Treatment and Research. 117: 307-36. PMID 15015567 DOI: 10.1007/978-1-4419-8871-3_18 |
0.323 |
|
| 2000 |
Puduvalli VK, Sawaya R. Antiangiogenesis - Therapeutic strategies and clinical implications for brain tumors Journal of Neuro-Oncology. 50: 189-200. PMID 11245279 DOI: 10.1023/A:1006469830739 |
0.302 |
|
| Show low-probability matches. |